Back
Natera Inc (NTRA)
BiotechnologyNTRA · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$331.83
+2.17%Weekly undervalued picks
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$-1.52
ROE
-15.0%
Gross margin
65.1%
Debt/Equity
0.14x
Revenue growth
38.8%
Natera Inc — company intelligence
Earnings surprises
Q2 2026$-0.47 vs $-0.50 est+6.7%
Q1 2026$-0.60 vs $-0.55 est-9.7%
Q4 2025$0.36 vs $-0.52 est+169.1%
Q3 2025$-0.64 vs $-0.38 est-68.2%
Analyst consensus · 30 analysts
26 Buy4 Hold0 Sell
Updated Aug 16, 2026
Insider activity · 90 days
1 buy143 sellsnet -357,574 shares
Sheena JonathanSell 6,000 · Aug 10, 2026
Sheena JonathanSell 100 · Aug 7, 2026
Sheena JonathanSell 850 · Aug 7, 2026
Recent SEC filings
4 — Insider transaction reportAug 14, 2026
4 — Insider transaction reportAug 7, 2026
4 — Insider transaction reportAug 7, 2026
Latest news
Natera: Even 30% Annual Growth Through 2030 Doesn't Support $310 Per Share — SeekingAlpha · 6d ago
Here's How Much $1000 Invested In Natera 10 Years Ago Would Be Worth Today — Benzinga · 1w ago
Citigroup Maintains Buy on Natera, Raises Price Target to $365 — Benzinga · 1w ago
Natera, Inc. (NTRA) Presents at Canaccord Genuity's 46th Annual Growth Conference Transcript — SeekingAlpha · 1w ago
Piper Sandler Maintains Overweight on Natera, Raises Price Target to $363.5 — Benzinga · 1w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.